These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 28224391)

  • 1. Development and Evaluation of a Nanoemulsion Containing Ursolic Acid: a Promising Trypanocidal Agent : Nanoemulsion with Ursolic Acid Against T. cruzi.
    Vargas de Oliveira EC; Carneiro ZA; de Albuquerque S; Marchetti JM
    AAPS PharmSciTech; 2017 Oct; 18(7):2551-2560. PubMed ID: 28224391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid dispersion of ursolic acid in Gelucire 50/13: a strategy to enhance drug release and trypanocidal activity.
    de Oliveira Eloy J; Saraiva J; de Albuquerque S; Marchetti JM
    AAPS PharmSciTech; 2012 Dec; 13(4):1436-45. PubMed ID: 23070562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoemulsions for dermal controlled release of oleanolic and ursolic acids: In vitro, ex vivo and in vivo characterization.
    Alvarado HL; Abrego G; Souto EB; Garduño-Ramirez ML; Clares B; García ML; Calpena AC
    Colloids Surf B Biointerfaces; 2015 Jun; 130():40-7. PubMed ID: 25899842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro trypanocidal activity of triterpenes from miconia species.
    Cunha WR; Martins C; da Silva Ferreira D; Crotti AE; Lopes NP; Albuquerque S
    Planta Med; 2003 May; 69(5):470-2. PubMed ID: 12802734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tailoring microstructural, drug release properties, and antichagasic efficacy of biocompatible oil-in-water benznidazol-loaded nanoemulsions.
    Streck L; Sarmento VHV; de Menezes RPRPB; Fernandes-Pedrosa MF; Martins AMC; da Silva-Júnior AA
    Int J Pharm; 2019 Jan; 555():36-48. PubMed ID: 30448310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanocidal activity and acute toxicity assessment of triterpene acids.
    Ferreira Dda S; Esperandim VR; Toldo MP; Saraiva J; Cunha WR; de Albuquerque S
    Parasitol Res; 2010 Mar; 106(4):985-9. PubMed ID: 20140451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo activity of ursolic and oleanolic acids during the acute phase of Trypanosoma cruzi infection.
    da Silva Ferreira D; Esperandim VR; Toldo MP; Kuehn CC; do Prado Júnior JC; Cunha WR; e Silva ML; de Albuquerque S
    Exp Parasitol; 2013 Aug; 134(4):455-9. PubMed ID: 23648663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period.
    Duschak VG
    Recent Pat Antiinfect Drug Discov; 2016; 11(2):74-173. PubMed ID: 27784230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform.
    Choudhury H; Gorain B; Karmakar S; Biswas E; Dey G; Barik R; Mandal M; Pal TK
    Int J Pharm; 2014 Jan; 460(1-2):131-43. PubMed ID: 24239580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of the trypanocidal activity of triterpene acids isolated from Miconia species.
    Cunha WR; Crevelin EJ; Arantes GM; Crotti AE; Andrade e Silva ML; Furtado NA; Albuquerque S; Ferreira Dda S
    Phytother Res; 2006 Jun; 20(6):474-8. PubMed ID: 16619351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NANOEMULSION WITH CLOTRIMAZOLE - DESIGN AND OPTIMALIZATION OF MEAN DROPLET SIZE USING MICROFLUIDIZATION TECHNIQUE.
    Sosnowska K; Szymanska E; Winnicka K
    Acta Pol Pharm; 2017 Mar; 74(2):519-526. PubMed ID: 29624257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Terpene Type on the Release from an O/W Nanoemulsion: Experimental and Theoretical Studies.
    Miastkowska M; Śliwa P
    Molecules; 2020 Jun; 25(12):. PubMed ID: 32545817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasonic emulsification of parenteral valproic acid-loaded nanoemulsion with response surface methodology and evaluation of its stability.
    Tan SF; Masoumi HR; Karjiban RA; Stanslas J; Kirby BP; Basri M; Basri HB
    Ultrason Sonochem; 2016 Mar; 29():299-308. PubMed ID: 26585010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoemulsion: a promising tool for solubility and dissolution enhancement of celecoxib.
    Shakeel F; Faisal MS
    Pharm Dev Technol; 2010; 15(1):53-6. PubMed ID: 19552546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebulized oil-in-water nanoemulsion mists for pulmonary delivery: development, physico-chemical characterization and in vitro evaluation.
    Nesamony J; Shah IS; Kalra A; Jung R
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1253-63. PubMed ID: 23837519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curcumin nanoemulsion for transdermal application: formulation and evaluation.
    Rachmawati H; Budiputra DK; Mauludin R
    Drug Dev Ind Pharm; 2015 Apr; 41(4):560-6. PubMed ID: 24502271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoemulsion: for improved oral delivery of repaglinide.
    Akhtar J; Siddiqui HH; Fareed S; Badruddeen ; Khalid M; Aqil M
    Drug Deliv; 2016 Jul; 23(6):2026-34. PubMed ID: 27187792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clotrimazole nanoemulsion for malaria chemotherapy. Part I: preformulation studies, formulation design and physicochemical evaluation.
    Borhade V; Pathak S; Sharma S; Patravale V
    Int J Pharm; 2012 Jul; 431(1-2):138-48. PubMed ID: 22227344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral delivery of ursolic acid-loaded nanostructured lipid carrier coated with chitosan oligosaccharides: Development, characterization, in vitro and in vivo assessment for the therapy of leishmaniasis.
    Das S; Ghosh S; De AK; Bera T
    Int J Biol Macromol; 2017 Sep; 102():996-1008. PubMed ID: 28465178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.